Article Information
History
- May 5, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Adrian W. Briggs1,2*,
- Stephen J. Goldfless1,2*,
- Sonia Timberlake1*,
- Brian J. Belmont1,2,
- Christopher R. Clouser1,2,
- David Koppstein1,
- Devin Sok3,4,5,
- Jason Vander A. Heiden6,
- Manu V. Tamminen7,
- Steven H. Kleinstein6,8,9,
- Dennis R. Burton4,5,10,11,
- George M. Church12 and
- Francois Vigneault1,2
- 1AbVitro Inc., Boston, MA, USA.
- 2Current: Juno Therapeutics Inc., 307 Westlake Avenue N, Seattle, WA 98109, USA
- 3International AIDS Vaccine Initiative, New York, NY 10038, USA
- 4IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA
- 5Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), The Scripps Research Institute, La Jolla, CA 92037, USA
- 6Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511;
- 7Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- 8Department of Pathology, Yale University School of Medicine, Yale University, New Haven, CT 06511, USA
- 9Department of Immunobiology, Yale University School of Medicine, Yale University, New Haven, CT 06511, USA
- 10Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA
- 11Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA 02142
- 12Harvard Medical School, Boston, MA, USA
↵* These authors contributed equally